102 related articles for article (PubMed ID: 29162271)
1. Familial pancreatic cancer asociated to germline mutation of BRCA2.
Sánchez Bermúdez AI; Marín Zafra G; Sarabia Meseguer MD
Med Clin (Barc); 2018 Apr; 150(8):e19-e20. PubMed ID: 29162271
[No Abstract] [Full Text] [Related]
2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
3. A BRCA2 germ-line mutation in familial pancreatic carcinoma.
White K; Held KR; Weber BH
Int J Cancer; 2001 Mar; 91(5):742-4. PubMed ID: 11267991
[No Abstract] [Full Text] [Related]
4. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
[TBL] [Abstract][Full Text] [Related]
5. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
Real FX; Malats N; Lesca G; Porta M; Chopin S; Lenoir GM; Sinilnikova O;
Gut; 2002 May; 50(5):653-7. PubMed ID: 11950811
[TBL] [Abstract][Full Text] [Related]
6. BRCA2 germline mutations in familial pancreatic carcinoma.
Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
[TBL] [Abstract][Full Text] [Related]
7. Assessing the Significance of BRCA1 and BRCA2 Mutations in Pancreatic Cancer.
Carnevale J; Ashworth A
J Clin Oncol; 2015 Oct; 33(28):3080-1. PubMed ID: 25987697
[No Abstract] [Full Text] [Related]
8. BRCA2 and pancreatic cancer.
Naderi A; Couch FJ
Int J Gastrointest Cancer; 2002; 31(1-3):99-106. PubMed ID: 12622420
[TBL] [Abstract][Full Text] [Related]
9. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
Cho JH; Bang S; Park SW; Chung JB; Song SY
Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
[TBL] [Abstract][Full Text] [Related]
10. Targeting reactive nitrogen species suppresses hereditary pancreatic cancer.
Li M; Chen Q; Ma T; Yu X
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7106-7111. PubMed ID: 28630313
[TBL] [Abstract][Full Text] [Related]
11. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers.
de Mestier L; Danset JB; Neuzillet C; Rebours V; Cros J; Soufir N; Hammel P
Endocr Relat Cancer; 2016 Oct; 23(10):T57-67. PubMed ID: 27511924
[TBL] [Abstract][Full Text] [Related]
13. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Roberts NJ; Norris AL; Petersen GM; Bondy ML; Brand R; Gallinger S; Kurtz RC; Olson SH; Rustgi AK; Schwartz AG; Stoffel E; Syngal S; Zogopoulos G; Ali SZ; Axilbund J; Chaffee KG; Chen YC; Cote ML; Childs EJ; Douville C; Goes FS; Herman JM; Iacobuzio-Donahue C; Kramer M; Makohon-Moore A; McCombie RW; McMahon KW; Niknafs N; Parla J; Pirooznia M; Potash JB; Rhim AD; Smith AL; Wang Y; Wolfgang CL; Wood LD; Zandi PP; Goggins M; Karchin R; Eshleman JR; Papadopoulos N; Kinzler KW; Vogelstein B; Hruban RH; Klein AP
Cancer Discov; 2016 Feb; 6(2):166-75. PubMed ID: 26658419
[TBL] [Abstract][Full Text] [Related]
14. PALB2 analysis in BRCA2-like families.
Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
[TBL] [Abstract][Full Text] [Related]
15. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
16. No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.
Grützmann R; McFaul C; Bartsch DK; Sina-Frey M; Rieder H; Koch R; McCarthy E; Greenhalf W; Neoptolemos JP; Saeger HD; Pilarsky C
Cancer Lett; 2004 Oct; 214(1):63-8. PubMed ID: 15331174
[TBL] [Abstract][Full Text] [Related]
17. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
[TBL] [Abstract][Full Text] [Related]
19. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.
Huang L; Wu C; Yu D; Wang C; Che X; Miao X; Zhai K; Chang J; Jiang G; Yang X; Cao G; Hu Z; Zhou Y; Zuo C; Wang C; Zhang X; Zhou Y; Yu X; Dai W; Li Z; Shen H; Liu L; Chen Y; Zhang S; Wang X; Liu Y; Sun M; Cao W; Gao J; Ma Y; Zheng X; Cheung ST; Jia Y; Tan W; Wu T; Lin D
Carcinogenesis; 2013 May; 34(5):1001-5. PubMed ID: 23299404
[TBL] [Abstract][Full Text] [Related]
20. BRCA and pancreatic cancer.
Brennan GT; Relias V; Saif MW
JOP; 2013 Jul; 14(4):325-8. PubMed ID: 23846919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
